Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.38%
SPX
+0.88%
IXIC
+1.31%
FTSE
+0.61%
N225
+1.03%
AXJO
+0.39%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
Health Care
xfor
X4 Pharmaceuticals
NASDAQ: XFOR
-0.08 (-2.19%)
3.58
USD
At close at Dec 19, 21:43 UTC
Summary
News
Signals
Benchmarks
Financials

Latest Cashu News

No Cashu articles
X4 Pharmaceuticals currently has no Cashu-related articles

Latest X4 Pharmaceuticals News

finance.yahoo.com

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq ListingRule 5635(c)(4)

Feature Image for interests on Immune System, Inc., Nasdaq, Stock from finance.yahoo.com
about 1 year ago
finance.yahoo.com

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) is a favorite amongst institutional investors who own 51%

Feature Image for interests on Analyst Forecasts, Individual Investors, Insider Ownership, Institutional Investors from finance.yahoo.com
over 1 year ago
finance.yahoo.com

X4 Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

Feature Image for interests on Chronic Neutropenia, Clinical Trial, Mavorixafor, Pharmaceuticals from finance.yahoo.com
over 1 year ago
benzinga.com

5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More

Feature Image for interests on Arwr, Benzinga, Biotech, Dskyf from benzinga.com
over 1 year ago
finance.yahoo.com

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feature Image for interests on Immune System, Inc., Nasdaq, Stock from finance.yahoo.com
over 1 year ago
finance.yahoo.com

X4 Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates

Feature Image for interests on American Society Of Hematology, Clinical Trial, Phase 2 Clinical Trial, Stock from finance.yahoo.com
over 1 year ago
finance.yahoo.com

X4 Pharmaceuticals to Report First-Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 7, 2024

Feature Image for interests on Immune System, Stock, Unknown Sector from finance.yahoo.com
over 1 year ago
benzinga.com

FDA Approves X4 Pharmaceuticals' Mavorixafor As First Therapy For Rare Immunodeficiency Disorder

Feature Image for interests on Benzinga, Biotech, Briefs, Fda from benzinga.com
over 1 year ago
benzinga.com

X4 Pharmaceuticals to Report Fourth-Quarter and Full Year 2023 Financial Results and Host a Conference Call and Webcast on March 21, 2024

almost 2 years ago
finance.yahoo.com

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq ListingRule 5635(c)(4)

Feature Image for interests on Nasdaq, Pharmaceuticals, Stock, Unknown Sector from finance.yahoo.com
almost 2 years ago
Join our newsletter to keep up to date with us!
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.